MAM
Monaco Asset Management Portfolio holdings
AUM
$264M
1-Year Est. Return
6.34%
1 Year Est. Return
+6.34%
AUM
$198M
AUM Growth
-$27.2M
(-12%)
Holding
99
Top Buys
| 1 | +$11.6M | |
| 2 | +$9.84M | |
| 3 | +$5.98M | |
| 4 |
Seadrill
SDRL
|
+$5M |
| 5 |
MAG
MAG Silver
MAG
|
+$4.5M |
Top Sells
| 1 | +$13.1M | |
| 2 | +$10.2M | |
| 3 | +$9.82M | |
| 4 |
Devon Energy
DVN
|
+$6.55M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$6.3M |
Sector Composition
| 1 | Healthcare | 32.49% |
| 2 | Materials | 26.55% |
| 3 | Communication Services | 16.92% |
| 4 | Energy | 6.03% |
| 5 | Financials | 3.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Novavax
NVAX
$1.32B
| $1.86M | 0.38% |
290,000
+5,000
|
|
||
27
Maravai LifeSciences
MRVI
$477M
| $1.85M | 0.38% |
835,865
+544,501
|
|
||
28
The Mosaic Company
MOS
$9.31B
| $1.76M | 0.36% |
65,000
|
|
||
29
Noble Corp
NE
$4.36B
| $1.66M | 0.34% |
70,000
+45,000
|
|
||
30
Schrodinger
SDGR
$1.42B
| $1.63M | 0.33% |
82,500
+2,500
|
|
||
31
QuidelOrtho
QDEL
$1.91B
| $1.57M | 0.32% |
45,000
-20,000
|
|
||
32
Nkarta
NKTX
$163M
| $1.5M | 0.31% |
+813,116
|
|
||
33
Vanda Pharmaceuticals
VNDA
$311M
| $1.49M | 0.3% |
325,000
-67,262
|
|
||
34
JD.com
JD
$46.9B
| $1.44M | 0.29% |
+35,000
|
|
||
35
B2Gold
BTG
$7.34B
| $1.43M | 0.29% |
500,000
-800,000
|
|
||
36
Ventyx Biosciences
VTYX
$280M
| $1.3M | 0.27% |
1,134,444
+894,444
|
|
||
37
Roivant Sciences
ROIV
$11.8B
| $1.21M | 0.25% |
120,000
-15,000
|
|
||
38
Inogen
INGN
$226M
| $1.19M | 0.24% |
167,594
+91,094
|
|
||
39
Banco Bradesco
BBD
$34.9B
| $1.17M | 0.24% |
525,000
+75,000
|
|
||
40
Green Plains
GPRE
$732M
| $1.09M | 0.22% |
225,000
+122,722
|
|
||
41
Forum Energy Technologies
FET
$319M
| $1.05M | 0.21% |
52,206
-22,912
|
|
||
42
Weatherford International
WFRD
$4.47B
| $1.02M | 0.21% |
+19,000
|
|
||
43
Ginkgo Bioworks
DNA
$784M
| $1.01M | 0.21% |
177,500
-207,164
|
|
||
|
MREO
44
Mereo BioPharma
MREO
$326M
| $937K | 0.19% |
416,468
+35,000
|
|
||
45
Fate Therapeutics
FATE
$170M
| $908K | 0.19% |
1,149,708
+822,037
|
|
||
46
Galapagos
GLPG
$2.27B
| $905K | 0.18% |
36,036
+21,036
|
|
||
47
Q32 Bio
QTTB
$38.7M
| $834K | 0.17% |
505,451
-69,365
|
|
||
48
uniQure
QURE
$3.57B
| $795K | 0.16% |
75,000
-61,708
|
|
||
49
Nektar Therapeutics
NKTR
$1.1B
| $727K | 0.15% |
71,260
-64,265
|
|
||
50
StoneCo
STNE
$4.78B
| $681K | 0.14% |
65,000
-110,000
|
|